219 related articles for article (PubMed ID: 28611572)
1. 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both
Hu J; Ferchmin PA; Hemmerle AM; Seroogy KB; Eterovic VA; Hao J
Front Neurosci; 2017; 11():272. PubMed ID: 28611572
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia.
Martins AH; Hu J; Xu Z; Mu C; Alvarez P; Ford BD; El Sayed K; Eterovic VA; Ferchmin PA; Hao J
Neuroscience; 2015 Apr; 291():250-259. PubMed ID: 25677097
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Evaluation of the Acute Systemic Toxicity of (1S,2E,4R,6R,7E,11E)-Cembratriene-4,6-diol (4R) in Sprague Dawley Rats.
Sabeva N; Pagán OR; Ferrer-Acosta Y; Eterović VA; Ferchmin PA
Nutraceuticals (Basel); 2022 Jun; 2(2):60-70. PubMed ID: 35855209
[TBL] [Abstract][Full Text] [Related]
4. Protective activity of (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol analogues against diisopropylfluorophosphate neurotoxicity: preliminary structure-activity relationship and pharmacophore modeling.
Eterović VA; Del Valle-Rodriguez A; Pérez D; Carrasco M; Khanfar MA; El Sayed KA; Ferchmin PA
Bioorg Med Chem; 2013 Aug; 21(15):4678-86. PubMed ID: 23769165
[TBL] [Abstract][Full Text] [Related]
5. 4R-cembranoid protects against diisopropylfluorophosphate-mediated neurodegeneration.
Ferchmin PA; Andino M; Reyes Salaman R; Alves J; Velez-Roman J; Cuadrado B; Carrasco M; Torres-Rivera W; Segarra A; Martins AH; Lee JE; Eterovic VA
Neurotoxicology; 2014 Sep; 44():80-90. PubMed ID: 24928201
[TBL] [Abstract][Full Text] [Related]
6. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
7. Determining the safety of the tobacco cembranoid (1S,2E,4R,6R,7E,11E)-Cembratriene-4,6-diol (4R): A translational study in nonhuman primates.
Sabeva N; Castro W; Acosta YF; Ferchmin PA; Eterović VA; Sierra-Mercado D; Rios NP; Rivas-Tumanyan S; Martins AH
Toxicol Appl Pharmacol; 2024 Jan; 482():116772. PubMed ID: 38036230
[TBL] [Abstract][Full Text] [Related]
8. Tobacco cembranoids protect the function of acute hippocampal slices against NMDA by a mechanism mediated by alpha4beta2 nicotinic receptors.
Ferchmin PA; Hao J; Perez D; Penzo M; Maldonado HM; Gonzalez MT; Rodriguez AD; de Vellis J
J Neurosci Res; 2005 Dec; 82(5):631-41. PubMed ID: 16247800
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease.
Murray TK; Messenger MJ; Ward MA; Woodhouse S; Osborne DJ; Duty S; O'Neill MJ
Pharmacol Biochem Behav; 2002 Sep; 73(2):455-66. PubMed ID: 12117601
[TBL] [Abstract][Full Text] [Related]
10. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
Xue YQ; Zhao LR; Guo WP; Duan WM
Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
[TBL] [Abstract][Full Text] [Related]
11. FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease.
Guo X; Liu T; Zhao D; Wang X; Liu D; He Y; Shan C; Kong Y; Hu W; Tao B; Sun L; Zhao H; Li S; Liu J
Neuroscience; 2017 Jul; 356():229-241. PubMed ID: 28504195
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease through the Inflammation Pathway.
Wei R; Rong C; Xie Q; Wu S; Feng Y; Wang R; Dai Z; Lin T
Evid Based Complement Alternat Med; 2019; 2019():2529641. PubMed ID: 31929812
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
15. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
17. Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β Signaling.
Guo XZ; Shan C; Hou YF; Zhu G; Tao B; Sun LH; Zhao HY; Ning G; Li ST; Liu JM
Front Mol Neurosci; 2018; 11():343. PubMed ID: 30319352
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
19. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
20. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction.
Wu CR; Tsai CW; Chang SW; Lin CY; Huang LC; Tsai CW
Chem Biol Interact; 2015 Jan; 225():40-6. PubMed ID: 25446857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
